Conquer the Common Cold

Breakthrough Drug-Free, Cold Relief is Here!

FEBRUARY 2020 UPDATE: Due to the current coronavirus (SARS-CoV-2) outbreak and the resulting Covid-19 global pandemic, I have released a free You Tube video that presents the core procedure originally described in Conquer the Common Cold and Flu so that everyone can have access to this potentially life-saving prevention and treatment without the need to purchase anything. The free video also includes more recent data than the audio book and has been optimized for coronavirus based on the most recent data available as of Feb, 20, 2020. Here is the link to a page with links to several versions of the video Stop COVID-19 Now!

CAUTION: This procedure presented in this video is NOT a cure for coronavirus! It has not yet been endorsed by any health authority. It should ONLY be considered as one more layer of prevention IN ADDITION TO OTHER PRECAUTIONS recommended by the CDC, WHO, or other health authorities. NOTE: Once the virus has migrated to the lungs, which may occur in up to 20% of patients within one to two weeks, the virus may be too far from the external heat source to be substantially impacted by inhaling hot air alone. You may wish to consider sauna use at this point, since it can elevate the temperature of the entire body. In all cases, benefits are likely to be highest when used early-on for prevention and early-stage treatment.

MAY 2009 UPDATE:”Though not yet confirmed in clinical trials, initial indications suggest that the H1N1 Flu Virus (Originally referred to in the media as “Spring 2009 Swine Flu”) is a type of virus that has the potential to respond to the ColdARREST™ procedure to significantly reduce or eliminate symptoms, particularly if used preventively, or at the earliest signs of illness.”

– Dän Lee Dimke, PhD

"I have not suffered from a cold in the past five years since I have been using the procedure described by Dr. Dän Lee Dimke."-Chris Vermeulen, Johannesburg , South Africa

The common cold is the most widespread and prevalent of all human diseases, striking as many as 200 times in the average lifetime. Colds often last from four days to two weeks bringing the more than twenty miserable symptoms we've come to associate with colds and flu.

Traditionally, there has been no cure or prevention for this disease. However, exciting, new, scientific evidence, resulting from an accident during research with polio virus, has suggested a simple, yet effective, procedure that anyone can use to actually destroy invading cold virus, for the first time.

The ColdARREST™ procedure works almost immediately. The result is incredibly rapid and lasting relief from cold symptoms. And, instead of merely masking symptoms, this procedure helps stimulate recovery from the disease, beginning just as soon as symptoms disappear. A revolutionary, new, cold-prevention system is also presented.

Children routinely catch three times as many colds as adults. Yet, with parental supervision, the ColdARREST™ Procedure is safe enough and gentle enough for a child to use, and just as effective.

NEW!! -- Less Colds or Your Money Back!*

For the benefit of physicians, chiropractors, and other medical professionals, a detailed bibliography of the extensive medical and biophysical research behind the procedure is also included in standard Index Medicus format.

"After listening to the audio program, I am now armed to put the cure into action the instant I need it. I recommend everyone try the methods in Conquer the Common Cold."

- David Miskimin, Cheshire, UK

	*Conquer*
	*The Common Cold & Flu*
	Comments from satisfied customers

My name is Chris Vermeulen and I live in Johannesburg, South Africa.

At first, my wife and child did not believe that the hot air treatment (as described in the program) would actually work. It is such a simple, easy-to-use technique that anyone can follow it. And what I like the most is the fact that if a cold is caused by a virus this method virtually always works. The positive results are immediate after the treatment. My family now uses the treatment all the time.I used to fall ill with a cold or flu at least four times a year. This meant I had to spend three to four days in bed each time. I no longer could afford the loss in income and my doctor could never give me anything to solve the problem. Then I found Conquer the Common Cold.

Now, if I wake up in the morning with the symptoms of a cold or flu, I apply the technique every hour for five hours. That same evening I go to bed as if I never knew of the virus in the morning. I have not spent any time in bed for the past five years as a result flu by using the procedure described by Dr. Dän Lee Dimke. I have also saved tremendously on unnecessary medical bills for my whole family.

Conquer the Common Cold truly is revolutionary in its approach to a problem every individual on this planet has to deal with.

The virus that causes colds and flu is constantly adapting and medical science has not found any drug that will cure you of the common cold or flu. Dr. Dimke's discovery treats the real cause of colds and flu by killing off the virus and giving you immediate relief of all the agonising symptoms of colds and flu.

The author, Dr. Dän Lee Dimke, Ph.D., is a remarkable man, and his presentations are very well researched and presented. All his products are worth having in your personal library.

I have been a ordering products from Future World since 1996 on a monthly basis. The service has always been outstanding and very professional. Never ever did anything go wrong with the shipping. The products always reached me in superb condition. And I live in Africa. This says something for Future World!!

My name is Anthony Beaumont. I live in Shelley, Yorkshire in the UK.

I saw Conquer the Common Cold on my Future World Web pages and as I and my family always seem to be get serious colds, I thought it would be a good investment in our health. I have tried it myself, and whilst I did not get the full kill, so to speak, I did get very much reduced symptoms and a much shorter period of suffering. I usually get only 2 or 3 colds per year, but when I do get them I usually suffer for two to three weeks, I start with a raw or sore throat first which can be for up to a week, then I get the nose dribbles for 3 to 5 days with the resulting sore nose, then followed by a chest cough. So all in all, the ColdARREST™ procedure worked well for me. I began using it at the first sign of the sore throat, this did not develop, I had 2 days of slightly runny nose, and no chest cough. I consider that a great success. I shall now continue with the cold prevention procedure regularly.

I find all of Dr. Dimke presentations most informative and enlightening. Everything is expressed in a clear, concise and easy to understand way that anyone can follow. And, the Future World Staff are the best, the ordering and service are second to none, speedy international delivery, prompt and courteous response to both e-mail and telephone calls.

My name is David Miskimin and I live in Wincham, Cheshire, England.

The Conquer the Common Cold cassette is superb - definitely not to be sniffed at! It is a classic "Dän Lee Dimke, Ph.D.", in that it gets straight to the point, whilst backing up the practicality with in-depth well-researched background information.The programme is totally informative with some staggering information I'd never even heard about let alone considered. Yet colds have been around forever! After listening to the cassette program, I am now armed to put the cure into action the instant I need it.

Dr. Dimke is a genius. He takes information that has been around, yet not widely revealed, and makes it understandable and practical. All this without fuss or spin. I recommend everyone try the methods in Conquer the Common Cold. Its so simple anyone can do it. Also, I received incredible service from Future World- fast, friendly, informative, and totally impressive.

My name is Ernst J. Plautz and I live outside of Random Lake, Wisconsin.

Awhile ago, a long while ago, I got information about Future World though the mail and joined. When Future World introduced Conquer the Common Cold I I did not get a copy right away, but I'm sure glad I finally did.

I think the information and the ideas and the research behind the ColdARREST™ procedure is fascinating and the procedure works great! I'm amazed at the results.

Hello. I'm Gene Wyngaard and I live in New Zealand and I am a technical sales engineer.

I heard about Conquer the Common Cold in a magazine a long time ago. I was a natural health sales representative when I bought the program. I listened to it a several times and thought it was very good and yes, easy to listen to. I have used the procedure many times and it certainly does work! Thank you.

My name is Neil Wilson and I live near the small village of Westruther in the Scottish Borders, U.K. (Basically, it is in the middle of nowhere, however it's peaceful and the scenery is wonderful.)

I first heard of Dr. Dimke after hearing an interview he gave to Peter Thomson, for his Achievers Edge programme in the UK. I also received a few of his tapes, such as the Free Phenomenon, Super Achievement and I was very impressed. I thereafter took a look at Future World, where I became a Communicator for some time (mainly to buy all of Dr. Dimke's courses at half price!) I have always been interested in health matters and was naturally drawn to the Conquer the Common Cold programme.

I found the research behind the ColdARREST™ procedure absolutely fascinating. To have read so much information on the subject left me in absolute awe. I have always found Dr. Dimke an immensely interesting person to listen to. He has a very distinctive and attractive style to his presentations.

I have used The Cold Arrest procedure on quite a few occasions. I have to say that the earlier it is used, the better, almost when you could feel a cold brewing in the back of your throat (that's where it always seems to come first with me). I have to say that personally my symptoms did not always relinquish, although the symptoms were not nearly as severe, compared to not having done the procedure.

Living in Scotland, I am never failed to be impressed by the speed of Future World's deliveries from America. My order invariably arrives quicker than an order from the UK. Ordering is easy (and I'm not meaning to suck up here, honest !) but I always found speaking to Linda an absolute pleasure. She is always happy and helpful without being over the top. "Have a nice day ya'll", if you know what I mean.

The following is excerpted from a February 24, 2003 Press Release from the University of Michigan Health Systems, Ann Arbor, MI -

Catching a cold isn't cheap. A study published in the February 24th edition of Archives of Internal Medicine reports that the cost to the U.S. economy is $40 billion a year - substantially more than other conditions such as asthma, heart failure and emphysema.

"A cold is the most commonly occurring illness in humans, so it was no surprise that there are approximately 500 million colds each year in the U.S.," says Mark Fendrick, M.D., lead author on the paper and codirector of the Consortium for Health Outcomes, Innovation, Cost Effectiveness Studies (CHOICES) at UMHS. "What was a surprise is how often the public uses the health care system to treat a cold."

The study measured doctor bills, over-the-counter medication, and prescription drugs. It also recorded missed school and work days, a cost that is generally overlooked, added Fendrick.

"The public doesn't usually consider the costs associated with missing a day of work due to illness or having to stay home to take care of a sick child", says Dr. Fendrick "Not surprisingly, lost work drives most of the cost."

The study found that Americans spend $2.9 billion on over-the-counter drugs and another $400 million on prescription medicines for symptomatic relief. Additionally, more than $1.1 billion are spent annually on the estimated 41 million antibiotic prescriptions for cold sufferers, even though antibiotics have no effect on a viral illness.

"We found that the common cold leads to more than 100 million physician visits annually at a conservative cost estimate of $7.7 billion per year," Fendrick says. "More than one third of patients who saw a doctor received an antibiotic prescription. While these unnecessary costs are problematic, what is more concerning is how these treatment patterns contribute to the development of antibiotic resistance, a significant public health concern."

The study reports that an estimated 189 million school days (an average of nearly 1 day per episode) are missed annually due to a cold. As a result, parents missed 126 million workdays in order to stay home to care for their child. When added to the workdays missed by employees suffering from a cold, the total economic impact of cold-related work loss exceeds $20 billion.

Written by: Carrie Hagen

* If you use the simple ColdARREST™ procedure, as described in this presentation, during the next cold season this fall and winter, (The difference between summer and winter colds is explained in the audio program) and you do not have less colds and/or drastically reduced symptoms, simply document your usage and symptoms and return the program for a complete refund.

The ColdARREST™ Procedure, seems to be equally effective in helping to prevent nearly all types of heat sensitive, common cold-causing viruses, including the entire coronavirus family as well as the current SARS-CoV-2 virus that causes COVID-19. We have reports from users who tested positive for Covid-19 who subsequently achieved complete remission of symptoms, within hours or days, following the use of the ColdARREST™ Procedure. This current coronavirus appears to the share same heat-sensitivity demonstrated by all others in this virus family. These anecdotal reports, while not a formal scientific study, do offer evidence that Covid-19 can be effectively treated with procedure. Should you elect to try this procedure yourself, remember to follow all procedures exactly as presented, using only the suggested heat sources. (Steam is NOT one of them). DO NOT use excessive levels of heat that cause ANY level of discomfort. DO NOT use older (pre-1990) external heat devices that are not equipped with a Ground-Fault Interrupt Circuit designed to prevent electric shock. Spray with distilled or previously-boiled water at room temperature whenever possible. Follow ALL manufacturer-recommended precautions for sauna use and begin with only 3 to 5-minute sessions. Then, increase exposure time gradually. Avoid sauna use entirely, if you are consuming alcohol, or have a fever or high blood pressure. And, consult your doctor, before using a sauna, if you are being treated for any medical condition or currently taking prescription medications. Safety first!

Update:

Since “Conquer the Common Cold and Flu” was originally written and produced, more than 30 years ago, we’ve learned considerably more about a particular class of common-cold-producing viruses, namely coronaviruses. While they were once relatively benign and appeared to live and reproduce only within the epithelial cells that line the sinuses, the SARS-CoV coronavirus and the current SARS-CoV-2 coronavirus (Severe Acute Respiratory Syndrome), that causes Covid-19, have, as their official title suggests, grown considerably more deadly than they were known to be in the mid 1980’s.

Most coronaviruses still predominantly live and replicate in the sinuses. But, as were have more recently learned, both SARS-CoV and SARS-CoV-2 (the virus that causes Covid-19) have been found to be able to move beyond the sinuses and migrate down the trachea to the lungs by slowly, but progressively attacking adjoining epithelial cells along this path. This appears to occur only in a small percentage of patients. In even fewer instances, coronaviruses may even spread to other organs of the body including the digestive tract and liver. This appears to occur only in very elderly and immune-compromised patients who may also have one or more underlying medical conditions, or patients who are taking immune-system-suppressing drugs. But, because we now know that it is possible for this to occur, it is important that it be noted, here.

Dan Lee Dimke, PhD - February 2020

Conquer the Common Cold and Flu™ and Cold-Arrest™

Bibliography

The Cold-Arrest™ Procedure is based on decades of scientific research into human upper-respiratory infections, the micro-organisms that cause them, and the procedures, medications and nutritional regimens capable of successfully mitigating or eradicating them. The following bibliography is current as of January 2012.

1. Gwaltney, J.M.Jr. 2000. The Common Cold. In Principles and Practices of Infectious Diseases, 5th ed. G.L. Mandell, J.E. Bennett, and R. Dolin, editors. Churchill Livingstone, New York. 651-656.

2. Gwaltney, J.M.Jr., J. Hendley, G. Simon, and W.S.J. Jordan. 1967. Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA. 202:494-500.

3. Treanor, J.J. 2000. Influenza virus. In Principles and Practice of Infectious Diseases, 5th ed. G.L. Mandell, J.E. Bennett, and R. Dolin, editors. Churchill Livingstone, New York. 1823-1849.

4. Gwaltney, J.M.Jr. 1997. Rhinoviruses. In Viral Infection of Humans: Epidemiology and Control, 4th ed. A.S. Evans, and R.A. Kaslow, editors. Plenum Press, New York. 815-838.

5. Gwaltney, J.M.Jr., and R.R. Ruckert. 1997. Rhinovirus. In Clinical Virology. D.D. Richman, R.J. Whitley, and F.G. Hayden, editors. Churhill Livingstone, New York. 1025-1047.

6. Hendley, J.O., R.P. Wenzel, and J.M. Gwaltney, Jr. 1973. Transmission of rhinovirus colds by self-inoculation. New England Journal of Medicine. 288:1361-1364.

7. Hendley, J.O., and J.M. Gwaltney, Jr. 1988. Mechanisms of transmission of rhinovirus infections. Epidemiologic Reviews. 10:243-258.

8. Douglas, R.G.J. 1970. Pathogenesis of rhinovirus common colds in human volunteers. Ann. Otol. Rhinol. Laryngol. 79:563-571.

9. Hendley, J.O., W.P. Edmondson, Jr., and J.M. Gwaltney, Jr. 1972. Relation between naturally acquired immunity and infectivity of two rhinoviruses in volunteers. Journal of Infectious Diseases. 125:243-248.

10. Winther, B., J.M. Gwaltney, Jr., N. Mygind, R.B. Turner, and J.O. Hendley. 1986. Sites of rhinovirus recovery after point inoculation of the upper airway. Jama. 256:1763-1767.

11. Abraham, G., and R.J. Colonno. 1984. Many rhinovirus serotypes share the same cellular receptor. J. Virol. 51:340-345.

12. Winther, B., J.M. Greve, J.M. Gwaltney, Jr., D.J. Innes, J.R. Eastham, A. McClelland, and J.O. Hendley. 1997. Surface expression of intercellular adhesion molecule 1 on epithelial cells in the human adenoid. Journal of Infectious Diseases. 176:523-525.

13. Harris, J.M., 2nd, and J.M. Gwaltney, Jr. 1996. Incubation periods of experimental rhinovirus infection and illness. Clinical Infectious Diseases. 23:1287-1290.

14. Turner, R.B., J.O. Hendley, and J.M. Gwaltney, Jr. 1982. Shedding of infected ciliated epithelial cells in rhinovirus colds. Journal of Infectious Diseases. 145:849-853.

15. Arruda, E., T.R. Boyle, B. Winther, D.C. Pevear, J.M. Gwaltney, Jr., and F.G. Hayden. 1995. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. Journal of Infectious Diseases. 171:1329-1333.

16. Naclerio, R.M., D. Proud, L.M. Lichtenstein, A. Kagey-Sobotka, J.O. Hendley, J. Sorrentino, and J.M. Gwaltney. 1988. Kinins are generated during experimental rhinovirus colds. Journal of Infectious Diseases. 157:133-142.

17. Proud, D., J.M. Gwaltney, Jr., J.O. Hendley, C.A. Dinarello, S. Gillis, and R.P. Schleimer. 1994. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. Journal of Infectious Diseases. 169:1007-1013.

18. Turner, R.B. 1994. Elaboration of interleukin 8 (IL-8) from fibroblast (MRC-5) cells and human nasal epithelium in response to rhinovirus (RV) challenge. 34th ICAAC, Orlando, FL:1994 (abstract).

19. Zhu, Z., W. Tang, J.M. Gwaltney, Jr., Y. Wu, and J.A. Elias. 1997. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. American Journal of Physiology. 273:L814-824.

20. Babe, K.S., and W.E. Serafin. 1996. Histamine, bradykinin, and their antagonists. In Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, and A.G. Gilman, editors. McGraw Hill, New York. 581-600.

21. Doyle, W.J., T.P. McBride, D.P. Skoner, B.R. Maddern, J.M. Gwaltney, Jr., and M. Uhrin. 1988. A double-blind, placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear and eustachian tube to provocative rhinovirus challenge. Pediatric Infectious Disease Journal. 7:229-238.

22. Gwaltney, J.M.Jr., J. Paul, D.A. Edelman, R.R. O’Connor, and R.B. Turner. 1996. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds. Clin. Infect Dis. 22:656-662.

23. Gwaltney, J.M., Jr., and H.M. Druce. 1997. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clinical Infectious Diseases. 25:1188-1194.

24. Gaffey, M.J., D.L. Kaiser, and F.G. Hayden. 1988. Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms. Pediatric Infectious Disease Journal. 7:223-228.

25. Insel, P.A. 1996. Analgesic-antipyretin and antiinflammatory agents and drugs employed in the treatment of gout. In Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, and A.G. Gilman, editors. McGraw Hill, New York. 617-657.

26. Nozhat, J.R.M., B. Choudry, and R.W. Fuller. 1990. The effect of sulindac on the abnormal cough reflex associated with dry cough. J. Pharmacol. Exper. Ther. 255:161-164.

27. Fogari, R., A. Zoppi, F. Tettamanti, G.D. Malamani, C. Tinelli, and A. Salvetti. 1992. Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: A double-blind, randomized, cross-over study. J Cardiovasc. Pharmacol. 19:670-673.

28. Sperber, S.J., J.O. Hendley, F.G. Hayden, D.K. Riker, J.V. Sorrentino, and J.M. Gwaltney, Jr. 1992. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial. Annals of Internal Medicine. 117:37-41.

29. Sperber, S.J., J.V. Sorrentino, D.K. Riker, and F.G. Hayden. 1989. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bulletin of the New York Academy of Medicine. 65:145-160.

30. Graham, N.M., C.J. Burrell, R.M. Douglas, P. Debelle, and L. Davies. 1990. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. Journal of Infectious Diseases. 162:1277-1282.

31. Hoffman, B.B., and R.J. Lefkowitz. 1996. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, and A.G. Gilman, editors. McGraw Hill, New York. 199-248.

32. Coates, M.L., C.M. Rembold, and B.M. Farr. 1995. Does pseudoephedrine increase blood pressure in patients with controlled hypertension? [see comments]. Journal of Family Practice. 40:22-26.

33. Brown, J.H., and P. Taylor. 1996. Muscarinic receptor agonists and antagonists. In Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, and A.G. Gilman, editors. McGraw Hill, New York. 141-160.

34. Gaffey, M.J., J.M. Gwaltney, Jr., W.E. Dressler, J.V. Sorrentino, and F.G. Hayden. 1987. Intranasally administered atropine methonitrate treatment of experimental rhinovirus colds. American Review of Respiratory Disease. 135:241-244.

35. Gaffey, M.J., F.G. Hayden, J.C. Boyd, and J.M. Gwaltney, Jr. 1988. Ipratropium bromide treatment of experimental rhinovirus infection. Antimicrobial Agents & Chemotherapy. 32:1644-1647.

36. Hayden, F.G., L. Diamond, P.B. Wood, D.C. Korts, and M.T. Wecker. 1996. Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine. 125:89-97.

37. Reisine, T., and G. Pasternak. 1996. Opioid analgesics and antagonists. In Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, and A.G. Gilman, editors. McGraw Hill, New York.

38. Freestone, C., and R. Eccles. 1997. Assessment of the antitussive efficacy of codeine in cough associated with common cold. Journal of Pharmacy & Pharmacology. 49:1045-1049.

39. Smith, M.B.H., and W. Feldman. 1991. A critical review of clinical trials between 1950 and 1991. JAMA. 269:2258-2263.

40. Gwaltney, J.M., Jr., C.D. Phillips, R.D. Miller, and D.K. Riker. 1994. Computed tomographic study of the common cold. New England Journal of Medicine. 330:25-30.

41. Gwaltney, J.M.Jr., J.O. Hendley, C.D. Phillips, C.R. Bass, N. Mygind, and B. Winther. 2000. Nose blowing propels nasal fluid into the paranasal sinuses. Clin. Infect. Dis. 30:387-391.

42. McBride, T.P., W.J. Doyle, F.G. Hayden, and J.M. Gwaltney, Jr. 1989. Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection. Archives of Otolaryngology — Head & Neck Surgery. 115:1054-1059.

43. Buchman, C.A., W.J. Doyle, D. Skoner, P. Fireman, and J.M. Gwaltney. 1994. Otologic manifestations of experimental rhinovirus infection. Laryngoscope. 104:1295-1299.

44. Elkhatieb, A., G. Hipskind, D. Woerner, and F.G. Hayden. 1993. Middle ear abnormalities during natural rhinovirus colds in adults. Journal of Infectious Diseases. 168:618-621.

45. Sperber, S.J., P.A. Levine, D.J. Innes, S.E. Mills, and F.G. Hayden. 1988. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults. Journal of Infectious Diseases. 158:166-175.

46. Dingle, J.H., G.F. Badger, and W.S.J. Jordan. 1964. Illness in the Home. A Study of 25,000 Illnesses in a Group of Cleveland Families. The Press of Western Reserve University, Cleveland. 347 pp.

47. Berg, O., C. Carenfelt, G. Rystedt, and A. Anggard. 1986. Occurrence of asymptomatic sinusitis in common cold and other acute ENT-infections. Rhinology. 24:223-225.

48. Gwaltney, J.M., Jr. 1996. Acute community-acquired sinusitis. Clinical Infectious Diseases. 23:1209-1223.

49. Gwaltney, J.M., Jr. 1999. Acute community acquired bacterial sinusitis: To treat or not to treat. Canadian Respiratory Journal. 6 Suppl A:46A-50A.

50. Gwaltney, J.M., Jr., W.M. Scheld, M.A. Sande, and A. Sydnor. 1992. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. Journal of Allergy & Clinical Immunology. 90:457-461.

51. Klein, J.O. 2000. Otitis externa, otitis media, mastoiditis. In Principles and Practice of Infectious Diseases, 5th ed. G.L. Mandell, J.E. Bennett, and R. Dolin, editors. Churchill Livingstone, New York. 669-675.

52. Guillemot, D., C. Carbon, B. Balkau, P. Geslin, H. Lecoeur, F. Vauzelle-Kervroedan, G. Bouvenot, and E. Eschwege. 1998. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. Jama. 279:365-370.

53. Pattemore, P.K., S.L. Johnston, and P.G. Bardin. 1992. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clinical & Experimental Allergy. 22:325-336.

54. Johnston, S.L., P. Pattemore, S. Smith, G. Sanderson, L. Josephs, P. Bardin, D. Tyrrell, and S. Holgate. 1991. The association of viral infections with longitudinal changes in respiratory symptoms and/or peak flow recordings in school children. Eur. Respir. J.:109s (abstract).

55. Nicholson, K.G., J. Kent, and D.C. Ireland. 1993. Respiratory viruses and exacerbations of asthma in adults. Brit. Med. J. 307:982-986.

56. Folkerts, G., W.W. Busse, F.P. Nijkamp, R. Sorkness, and J.E. Gern. 1998. Virus-induced airway hyperresponsiveness and asthma. American Journal of Respiratory & Critical Care Medicine. 157:1708-1720.

57. Gern, J.E., and W.W. Busse. 1999. Association of rhinovirus infections with asthma. Clinical Microbiology Reviews. 12:9-18.

58. Eadie, M.B., E.J. Stott, and N.R. Grist. 1966. Virological studies in chronic bronchitis. Brit. Med. J. 2:671-673.

59. McNamara, M.J., I.A. Phillips, and O.B. Williams. 1969. Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease. American Review of Respiratory Disease. 100:19-24.

60. Stenhouse, A.C. 1967. Rhinovirus infection in acute exacerbations of chronic bronchitis. A controlled prospective study. Brit. Med. J. 3:461-463.
61. Reynolds, H.Y. 1995. Chronic bronchitis and acute infectious exacerbations. In Principles and Practice of Infectious Diseases, 4th ed. G.L. Mandell, J.E. Bennett, and R. Dolin, editors. Churchill Livingstone, New York. 608-612.

62. D’Alessio, D.J., J.A. Peterson, C.R. Dick, and E.C. Dick. 1976. Transmission of experimental rhinovirus colds in volunteer married couples. Journal of Infectious Diseases. 133:28-36.

63. Dick, E.C., L.C. Jennings, K.A. Mink, C.D. Wartgow, and S.L. Inhorn. 1987. Aerosol transmission of rhinovirus colds. Journal of Infectious Diseases. 156:442-448.

64. Gwaltney, J.M., Jr., and J.O. Hendley. 1982. Transmission of experimental rhinovirus infection by contaminated surfaces. American Journal of Epidemiology. 116:828-833.

65. Reed, S.E. 1975. An investigation of the possible transmission of Rhinovirus colds through indirect contact. Journal of Hygiene. 75:249-258.

66. Gwaltney, J.M., Jr., P.B. Moskalski, and J.O. Hendley. 1978. Hand-to-hand transmission of rhinovirus colds. Annals of Internal Medicine. 88:463-467.

67. Hendley, J.O. 1998. Epidemiology, pathogenesis, and treatment of the common cold. Seminars Pediatr. Infect. Dis.:50-55.

68. Wald, E.R. 1992. Sinusitis in children. New England Journal of Medicine. 326:319-323.

69. Diehl, H.S. 1933. Medicinal treatment of the common cold. JAMA. 101:2042-2049.

70. Chalmers, T.C. 1975. Effects of ascorbic acid on the common cold: An evaluation of the evidence. Amer. J. Med. 53:532-536.

71. Fletcher, R.H., S.W. Fletcher, and E.H. Wagner. 1988. Clinical Epidemiology: The Essentials, 2nd ed. Williams and Wilkins, Baltimore.

72. Gwaltney, J.M.Jr., and F.G. Hayden. 1992. Response to psychological stress and susceptibility to the common cold. New Engl. J. Med. 326:644-645.

73. Andersen, I., G.R. Lundqvist, P.L. Jensen, and D.F. Proctor. 1974. Human response to 78-hour exposure to dry air. Archives of Environmental Health. 29:319-324.

74. Gwaltney, J.M., Jr. 1984. The Jeremiah Metzger lecture. Climatology and the common cold. Transactions of the American Clinical & Climatological Association. 96:159-175.

75. Gwaltney, J.M., Jr., J.O. Hendley, G. Simon, and W.S. Jordan, Jr. 1966. Rhinovirus infections in an industrial population. I. The occurrence of illness. New England Journal of Medicine. 275:1261-1268.

76. Douglas, R.G.J., K.M. Lindgren, and R.B. Couch. 1968. Exposure to cold environment and rhinovirus common cold. Failure to demonstrate effect. New Engl. J. Med. 279:743.

77. Pinnock, C.B., N.M. Graham, A. Mylvaganam, and R.M. Douglas. 1990. Relationship between milk intake and mucus production in adult volunteers challenged with rhinovirus-2. American Review of Respiratory Disease. 141:352-356.

78. E Ernst 1, E Pecho, P Wirz, T Saradeth, Ann Med, 22 (4), 225-7 1990, Regular Sauna Bathing and the Incidence of Common Colds, Affiliations expand PMID: 2248758 • DOI: 10.3109/07853899009148930.

79. Shu-Ming Duan 1, Xin-Sheng Zhao, Rui-Fu Wen, Jing-Jing Huang, Guo-Hua Pi, Su-Xiang Zhang, Jun Han, Sheng-Li Bi, Li Ruan, Xiao-Ping Dong, SARS Research Team, Biomed Environ Sci 2003 Sep:16(3):246-55, Affiliation: 1Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Ying-Xin Rd. 100, Beijing 100052, China.
PMID: 14631830

80. P. N. Lelie, corresponding author 1 H. W. Reesink, 1 and C. J. Lucas 1, J Med Virol. 1987 Nov; 23(3): 297–301, Published online 2005 Dec 7. doi: 10.1002/jmv.1890230313, PMCID: PMC7166500, PMID: 2828525, Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine

81. Sandy McGregor and Heather D. Mayor, Biophysical Studies on Rhinovirus and Poliovirus, – Amorphology of Viral Ribonucleoprotein, Journal of Virology,, Feb. 1968, p. 149-154, Vol. 2, No. 2.

82. Jari A. Laukkanen, MD, PhD Tanjaniina Laukkanen, MSc, Setor K. Kunutsor, MD, PhD, Cardiovascular and Other Health Benefits of Sauna Bathing: A Review of the Evidence, Mayo lLinic Proceedings, August 2018 Volume 93, Issue 8, Pages 1111–1121
83. K. H. Chan , J. S. Malik Peiris, S. Y. Lam, L. L. M. Poon, K. Y. Yuen, and W. H. Seto, The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus, Advances in Virology – Volume 2011, Article ID 734690 | 7 pages | https://doi.org/10.1155/2011/734690